Skip to main content
Caplight Logo









Ubiquigent Limited

Ubiquigent Limited

Private
DundeeHealthcare & Life Scienceshttps://ubiquigent.com/

Last Round

Grant

Jan 14, 2021

Total Funding Raised

$5.32M

Company Overview

Ubiquigent Limited is a biotechnology company that provides drug discovery services and develops novel deubiquitinase (DUB) modulators as therapeutics for areas of high unmet medical need.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Revenue Share

AI Layer

Non-AI

Keywords

ubiquitin-proteasome systemUPStargeted protein degradationdeubiquitylaseDUBdrug discovery servicescontract research organizationCRODUBprofilerproteolysis targeting chimeraPROTACsmall molecule therapeuticschemical biology toolsassay developmentbiotech research partner

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ubiquigent Limited Comparables

Compare Ubiquigent Limited with similar companies based on industry and business-model similarity.

Ubiquigent Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LifeSensors, Inc.
86%
Progenra, Inc.
83%
Trilogie Bioscience
81%

Ubiquigent Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 14, 2021
SeedSep 18, 2013
Corporate FundingMar 10, 2010

Ubiquigent Limited Investors

Notable investors and investment history

Ubiquigent Limited investors
InvestorRounds
IP GroupSeed
UKRI Innovate UKGrant
Scottish Investment Bank (Scottish Enterprise)Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 18, 2013

    $790K round with IP Group and Scottish Investment Bank

  • Mar 10, 2010

    $4.53M round led by ReproCELL Incorporated

Ubiquigent Limited Filings

Explore SEC and related filing metadata, where available.

Ubiquigent Limited filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ubiquigent Limited's valuation, stock price, and market status.

Is Ubiquigent Limited a public or private company?

Ubiquigent Limited is a private company.

What is the current stock price of Ubiquigent Limited?

Ubiquigent Limited is a private company with no public stock price. No recent secondary market data is available.

How much is Ubiquigent Limited worth (valuation)?

Valuation information for Ubiquigent Limited is not publicly available.

Can I buy Ubiquigent Limited stock?

Ubiquigent Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ubiquigent Limited's last funding round?

Ubiquigent Limited's most recent funding round was Grant on January 14, 2021.

Who are the main investors in Ubiquigent Limited?

Key investors in Ubiquigent Limited include IP Group, UKRI Innovate UK, Scottish Investment Bank (Scottish Enterprise).

Will Ubiquigent Limited IPO soon?

No public IPO plans have been announced for Ubiquigent Limited.

How can I track Ubiquigent Limited secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ubiquigent Limited's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDundee
Employee Range1
Year Founded2009
Last FundingJan 14, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?